+Članak 8. Izvješće i preispitivanje
---+Article 8 1.
---+Article 8 2.
---+Article 8 3.

Članak 8. Izvješće i preispitivanje

Članak 8.

Izvješće i preispitivanje

1.  Najkasnije do 31. prosinca 2010., Komisija dostavlja Europskom parlamentu i Vijeću izvješće utemeljeno na:

(a) iskustvu stečenom u primjeni ove Direktive,

(b) rezultatima posebno najnovijih znanstvenih istraživanja u vezi s učincima na zdravlje ljudi, posebno obraćajući pozornost na osjetljive skupine stanovništva i na okoliš kao cjelinu, o izloženosti arsenu, kadmiju, živi, niklu i policikličkim aromatskim ugljikovodicima, i

(c) tehnološkom razvoju, uključujući napredak u mjernim metodama ili na drugi način procijenjenim koncentracijama ovih onečišćujućih tvari u zraku kao i njihovih taloženja.

2.  Izvješće iz stavka 1. uzima u obzir:

(a) trenutačnu kvalitetu zraka, trendove i projekcije do i nakon 2015.;

(b) mogućnost daljnjeg smanjenja emisija onečišćujućih tvari popisanih u Prilogu I. iz svih relevantnih izvora i moguće prednosti uvođenja graničnih vrijednosti u svrhu smanjenja opasnosti za zdravlje ljudi, uzimajući u obzir tehničku izvedivost i isplativost troškova te svaki dodatni oblik zaštite zdravlja i okoliša koji bi se time postigao;

(c) odnose između onečišćujućih tvari i mogućnosti za korištenje kombiniranih strategija radi poboljšanja kvalitete zraka u Zajednici i srodnih ciljeva;

(d) postojeće i buduće zahtjeve za obavješćivanjem javnosti i za razmjenom informacija između država članica i Komisije;

(e) iskustvo stečeno u primjeni ove Direktive u državama članicama, te posebno uvjete u kojima se mjerenje provodi, kako je propisano u Prilogu III.;

(f) sekundarnu ekonomsku korist za okoliš i zdravlje ljudi od smanjenja emisija arsena, kadmija, žive, nikla i policikličkih aromatskih ugljikovodika do stupnja koji se može procijeniti;

(g) prikladnost veličine frakcije čestica koja se koristi za uzorkovanje, s obzirom na opće uvjete mjerenja lebdećih čestica;

(h) prikladnost benzo(a)pirena kao pokazatelja za ukupnu kancerogenu aktivnost policikličkih aromatskih ugljikovodika, uzimajući u obzir pretežno plinovite oblike policikličkih aromatskih ugljikovodika, kao što je fluoranten.

S obzirom na najnovija znanstvena i tehnička dostignuća Komisija preispituje i učinak arsena, kadmija i nikla na zdravlje ljudi, radi kvantificiranja njihove genotoksične kancerogenosti. Uzimajući u obzir mjere usvojene u skladu sa strategijom za živu, Komisija razmatra i moguće prednosti poduzimanja daljnjih radnji u vezi sa živom, uzimajući u obzir tehničku izvedivost i isplativost troškova te svaki značajniji dodatni oblik zaštite zdravlja i okoliša koji bi se time postigao.

3.  S ciljem postizanja razina koncentracija u zraku koje bi nadalje smanjile štetne učinke na zdravlje ljudi te bi dovele do visoke razine zaštite okoliša kao cjeline, uzimajući u obzir tehnički razvoj i isplativost troškova daljnjih radnji, izvješće iz stavka 1. može, ako je potrebno, biti popraćeno prijedlozima za izmjene ove Direktive, uzimajući u obzir posebno rezultate dobivene u skladu sa stavkom 2. Uz to, Komisija razmatra i reguliranje taloženja arsena, kadmija, žive, nikla i specifičnih policikličkih aromatskih ugljikovodika.

1. Pregled

,
Article 8 1.

The Commission shall, by 31 December 2010 at the latest, submit to the European Parliament and the Council a report based on:

(a) 

the experience acquired in the application of this Directive,

(b) 

in particular, the results of the most recent scientific research concerning the effects on human health, paying particular attention to sensitive populations, and on the environment as a whole, of exposure to arsenic, cadmium, mercury, nickel and polycyclic aromatic hydrocarbons, and

(c) 

technological developments including the progress achieved in methods of measuring and otherwise assessing concentrations of these pollutants in ambient air as well as their deposition.
Article 8 2.

The report referred to in paragraph 1 shall take into account:

(a) 

current air quality, trends and projections up to and beyond 2015;

(b) 

the scope for making further reductions in polluting emissions from all relevant sources, and the possible merit in introducing limit values aimed at reducing the risk to human health, for the pollutants listed in Annex I, taking account of technical feasibility and cost-effectiveness and any significant additional health and environmental protection that this would provide;

(c) 

the relationships between pollutants and opportunities for combined strategies for improving Community air quality and related objectives;

(d) 

current and future requirements for informing the public and for the exchange of information between Member States and Commission;

(e) 

the experience acquired in the application of this Directive in Member States, and in particular the conditions under which measurement has been carried out as laid down in Annex III;

(f) 

secondary economic benefits for the environment and health in reducing the emissions of arsenic, cadmium, mercury, nickel and polycyclic aromatic hydrocarbons to the extent that these can be assessed;

(g) 

the adequacy of the particle size fraction used for sampling in view of general particulate matter measurement requirements;

(h) 

the suitability of benzo(a)pyrene as a marker for the total carcinogenic activity of polycyclic aromatic hydrocarbons, having regard to predominantly gaseous forms of polycyclic aromatic hydrocarbons such as fluoranthene.

In the light of the latest scientific and technological developments the Commission shall also examine the effect of arsenic, cadmium and nickel on human health with a view to quantifying their genotoxic carcinogenicity. Taking account of measures adopted pursuant to the mercury strategy the Commission shall also consider whether there would be merit in taking further action in relation to mercury, taking account of technical feasibility and cost-effectiveness and any significant additional health and environmental protection that this would provide.
Article 8 3.
With a view to achieving levels of ambient air concentrations that would further reduce harmful effects on human health and would lead to a high level of protection of the environment as a whole, taking into account the technical feasibility and cost-effectiveness of further action, the report referred to in paragraph 1 may be accompanied, if appropriate, by proposals for amendments to this Directive, particularly taking into account the results obtained in accordance with paragraph 2. In addition the Commission shall consider regulating the deposition of arsenic, cadmium, mercury, nickel and specific polycyclic aromatic hydrocarbons.

1.1 Reference

1.2 Utvrđeni zahtjevi

1.3 Povezani standardi

2. Utvrđeni zahtjevi

Zahtjevi

3. Povezani standardi

Standardi
  • Builddate: 18.09.2015 00:00:00 -Doknr: CELEX:32004L0107
  • EULAW -

    EN: Legal acts of the European Union from EUR-Lex, https://eur-lex.europa.eu/. © European Union. Re-use is authorised by Decision 2011/833/EU, provided the source is acknowledged; the consolidated texts are licensed under CC BY 4.0 (EUR-Lex legal notice). Divided into sections and converted into the GRCA format, the wording unchanged. Only the legislation published in the Official Journal of the European Union is deemed authentic.

    DE: Rechtsakte der Europäischen Union aus EUR-Lex, https://eur-lex.europa.eu/. © Europäische Union. Weiterverwendung nach Beschluss 2011/833/EU mit Quellenangabe gestattet; die konsolidierten Fassungen stehen unter CC BY 4.0 (Rechtlicher Hinweis von EUR-Lex). In Abschnitte aufgeteilt und in das GRCA-Format umgewandelt, der Wortlaut unverändert. Verbindlich sind allein die im Amtsblatt der Europäischen Union veröffentlichten Rechtsakte.